Clinical Trial Update: A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [Phase 2]

View source ↗

Summary

BioMarin is conducting a Phase 2 trial of Vosoritide in children with idiopathic short stature, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Vosoritide (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Idiopathic Short Stature | Phase 2 | Status: RECRUITING